The vice president of Marconi Medical Systems' Asia/Pacific region has been named vice president and general manager of the company's huge Health Care Products division.Louis H. (Larry) Miller takes over HCP from Karl Wolcott, who will continue as a vice
The vice president of Marconi Medical Systems' Asia/Pacific region has been named vice president and general manager of the company's huge Health Care Products division.
Louis H. (Larry) Miller takes over HCP from Karl Wolcott, who will continue as a vice president reporting directly to Marconi president and CEO Fred Parks. Wolcott will be working on the company's healthcare information systems.
Medical imaging products make up more than one-third of the U.S. medical supplies market. Marconi launched Marconihcp.com in August (SCAN, 8/16/00) as a business-to-business Web site to serve the medical imaging supplies market. Through strategic alliances with large group purchasing organizations, the site offers purchasing options to 90% of U.S. hospitals.
Miller has been with Marconi Medical Systems for 15 years, beginning in MRI, and was president of Picker Financial Group when it was formed.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.